BLUEBIRD BIO, INC.

CAMBRIDGE, MA How do I update this listing?

Bluebird Bio is based out of Cambridge. Bluebird Bio, Inc., a clinical-stage biotechnology company, focuses on the development, manufacture, and marketing of therapies to treat various human diseases.Whalewisdom has at least 303 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2012-07-25. The notice included securities offered of Equity

Create Alert

Contact Info

bluebird bio, inc.
60 BINNEY STREET
CAMBRIDGE MA    02142

Business Phone: 339-499-9300
SEC SIC CODE:
2836-BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2012-07-25 D BIOTECHNOLOGY Equity 60,000,000 60,000,000 0
2011-04-27 D/A BIOTECHNOLOGY Equity,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 37,500,000 37,500,000 0
2011-04-27 D BIOTECHNOLOGY Equity 30,000,000 15,000,000 15,000,000
2010-03-19 D BIOTECHNOLOGY Equity,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 47,412,660 29,412,661 17,999,999
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
AXEL POLACK subscription required
    DIRECTOR
DANIEL S. LYNCH subscription required
    DIRECTOR
GEERT-JAN MULDER subscription required
    DIRECTOR
JAMES A. GERAGHTY subscription required
    DIRECTOR
JEFFREY T. WALSH subscription required
    EXECUTIVE OFFICER
JOHN M. MARAGANORE subscription required
    DIRECTOR
NICK LESCHLY subscription required
    EXECUTIVE OFFICER DIRECTOR
ROBERT TEPPER subscription required
    DIRECTOR
STEVEN GILLIS subscription required
    DIRECTOR

Elevate your investments